But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

Chinese government's recent drive to cut medical costs is causing a rare public backlash in Beijing and Shanghai, with doctors and patients saying that domestic generic drugs do not work as well ...

Alembic has received permission from the Food and Drug Administration for brexpiprazole tablets, which is the generic of Otsuka’s Rexulti. Brexpiprazole is an atypical antipsychotic used as an ...

including an experiment that involved offering generic medications for a $2 copay to Medicare Part D recipients. “This act is a good indication of how Trump will approach lower drug prices,” Social ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

Hospital chiefs and doctors in Beijing and Shanghai said the cheaper generic drugs mandated for use at public hospitals don’t appear to have the same efficacy or side effects as drugs from major ...

As a result, applying tariffs to generic medicines is likely to exacerbate the growing problem of drug shortages. All of this results from the unique value of the generic market. Unlike most other ...

The U.S. Court of Appeals for the Federal Circuit ordered MSN not to launch its drug, opens new tab while it considers Novartis' request for a longer ban on the generic version. The decision marks ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

open image in gallery Senior coroner for Gloucestershire Katy Skerrett is the latest in to have referenced either citalopram or sertraline in reports. (Getty Images) He suggested the drug should ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...